Skip to main content
Top
Published in: BMC Psychiatry 1/2013

Open Access 01-12-2013 | Research article

Melancholic and reactive depression: a reappraisal of old categories

Authors: Jin Mizushima, Hitoshi Sakurai, Yuya Mizuno, Masaki Shinfuku, Hideaki Tani, Kadunari Yoshida, Chisa Ozawa, Asako Serizawa, Natsuko Kodashiro, Shinya Koide, Atsumi Minamisawa, Eisaku Mutsumoto, Nobuhiro Nagai, Sachiko Noda, Genichiro Tachino, Tatsuichiro Takahashi, Hiroyoshi Takeuchi, Toshiaki Kikuchi, Hiroyuki Uchida, Koichiro Watanabe, Hiroki Kocha, Masaru Mimura

Published in: BMC Psychiatry | Issue 1/2013

Login to get access

Abstract

Background

The dominant diagnostic model of the classification of depression today is unitarian; however, since Kurt Schneider (1920) introduced the concept of endogenous depression and reactive depression, the binary model has still often been used on a clinical basis. Notwithstanding this, to our knowledge, there have been no collective data on how psychiatrists differentiate these two conditions. We therefore conducted a survey to examine how psychiatrists in Japan differentiate patients with major depressive disorder who present mainly with melancholic features and those with reactive features.

Methods

Three case scenarios of melancholic and reactive depression, and one-in-between were prepared. These cases were designed to present with at least 5 symptoms listed in the DSM-IV-TR with severity being mild. We have sent the questionnaires regarding treatment options and diagnosis for those three cases on a 7-point Likert scale (1 = “not appropriate”, 4 = “cannot tell”, and 7 = “appropriate”). Five hundred and two psychiatrists from over one hundred hospitals and community clinics throughout Japan have participated in this survey.

Results

The melancholic case resulted significantly higher than the reactive case on either antidepressants (mean ± SD: 5.9 ± 1.2 vs. 3.6 ± 1.7, p < 0.001), hypnotics (mean ± SD: 5.5 ± 1.1 vs. 5.0 ± 1.3, p < 0.001), and electroconvulsive therapy (mean ± SD: 1.5 ± 0.9 vs. 1.2 ± 0.6, p < 0.001). On the other hand, the reactive case resulted in significantly higher scores compared to the melancholic case and the one- in-between cases in regards to psychotherapy (mean ± SD: 4.9 ± 1.4 vs. 4.3 ± 1.4 vs. 4.7 ± 1.5, p < 0.001, respectively). Scores for informing patients that they suffered from “depression” were significantly higher in the melancholic case, compared to the reactive case (mean ± SD: 4.7 ± 1.7 vs. 2.2 ± 1.4, p < 0.001).

Conclusions

Japanese psychiatrists distinguish between major depressive disorder with melancholic and reactive features, and thus choose different treatment strategies regarding pharmacological treatment and psychotherapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Parker G: Classifying depression: should paradigms lost be regained?. Am J Psychiatry. 2000, 157 (8): 1195-1203. 10.1176/appi.ajp.157.8.1195.CrossRefPubMed Parker G: Classifying depression: should paradigms lost be regained?. Am J Psychiatry. 2000, 157 (8): 1195-1203. 10.1176/appi.ajp.157.8.1195.CrossRefPubMed
2.
go back to reference Fink M, Bolwig TG, Parker G, Shorter E: Melancholia: restoration in psychiatric classification recommended. Acta Psychiatr Scand. 2007, 115 (2): 89-92. 10.1111/j.1600-0447.2006.00943.x.CrossRefPubMedPubMedCentral Fink M, Bolwig TG, Parker G, Shorter E: Melancholia: restoration in psychiatric classification recommended. Acta Psychiatr Scand. 2007, 115 (2): 89-92. 10.1111/j.1600-0447.2006.00943.x.CrossRefPubMedPubMedCentral
3.
go back to reference American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders – DSM-IV-TR. 2000, Washington DC: American Psychiatric Association, Text Revision, 4 American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders – DSM-IV-TR. 2000, Washington DC: American Psychiatric Association, Text Revision, 4
4.
go back to reference World Health Organization: The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. 1992, Geneva: World Health Organization World Health Organization: The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. 1992, Geneva: World Health Organization
5.
go back to reference Bauer M, Bschor T, Pfenning A, Whybrow PC, Angst J, Versiani M, Möller HJ: World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry. 2007, 8 (2): 67-104. 10.1080/15622970701227829.CrossRefPubMed Bauer M, Bschor T, Pfenning A, Whybrow PC, Angst J, Versiani M, Möller HJ: World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry. 2007, 8 (2): 67-104. 10.1080/15622970701227829.CrossRefPubMed
6.
go back to reference Pilling S, Anderson I, Goldberg D, Meader N, Taylor C: Depression in adults, including those with a chronic physical health problem: summary of NICE guidance. BMJ. 2009, 339: b4108-10.1136/bmj.b4108.CrossRefPubMedPubMedCentral Pilling S, Anderson I, Goldberg D, Meader N, Taylor C: Depression in adults, including those with a chronic physical health problem: summary of NICE guidance. BMJ. 2009, 339: b4108-10.1136/bmj.b4108.CrossRefPubMedPubMedCentral
7.
go back to reference Ghaemi SN, Vohringer PA: The heterogeneity of depression: an old debate renewed. Acta Psychiatr Scand. 2011, 124: 497-10.1111/j.1600-0447.2011.01746.x.CrossRefPubMed Ghaemi SN, Vohringer PA: The heterogeneity of depression: an old debate renewed. Acta Psychiatr Scand. 2011, 124: 497-10.1111/j.1600-0447.2011.01746.x.CrossRefPubMed
8.
go back to reference Parker G, Fink M, Shorter E, Taylor MA, Akiskal H: Issues for DSM-5: whither melancholia? The case for its classification as a distinct mood disorder. Am J Psychiatry. 2010, 167 (7): 745-747. 10.1176/appi.ajp.2010.09101525.CrossRefPubMedPubMedCentral Parker G, Fink M, Shorter E, Taylor MA, Akiskal H: Issues for DSM-5: whither melancholia? The case for its classification as a distinct mood disorder. Am J Psychiatry. 2010, 167 (7): 745-747. 10.1176/appi.ajp.2010.09101525.CrossRefPubMedPubMedCentral
9.
10.
go back to reference Schneider K: Die Schichtung des emotionalen Lebens und der Aufbau der Depressionszustande. Z Gesamte Neurol Psychiatr. 1920, 59: 281-286. 10.1007/BF02901090.CrossRef Schneider K: Die Schichtung des emotionalen Lebens und der Aufbau der Depressionszustande. Z Gesamte Neurol Psychiatr. 1920, 59: 281-286. 10.1007/BF02901090.CrossRef
11.
go back to reference Carney MW, Roth M, Garside RF: The diagnosis of depressive syndromes and the prediction of E.C.T. response. Br J Psychiatry. 1965, 111: 659-674. 10.1192/bjp.111.477.659.CrossRefPubMed Carney MW, Roth M, Garside RF: The diagnosis of depressive syndromes and the prediction of E.C.T. response. Br J Psychiatry. 1965, 111: 659-674. 10.1192/bjp.111.477.659.CrossRefPubMed
12.
go back to reference Roth M, Gurney C, Mountjoy CQ: The Newcastle rating scales. Acta Psychiatr Scand Suppl. 1983, 310: 42-54.PubMed Roth M, Gurney C, Mountjoy CQ: The Newcastle rating scales. Acta Psychiatr Scand Suppl. 1983, 310: 42-54.PubMed
13.
go back to reference Gurney C: Diagnostic scales for affective disorders. In Proceedings of the fifth world conference of Psychiatry. 1971, Mexico City, 330- Gurney C: Diagnostic scales for affective disorders. In Proceedings of the fifth world conference of Psychiatry. 1971, Mexico City, 330-
14.
go back to reference Higuchi T: Major depressive disorder treatment guidelines in Japan. J Clin Psychiatry. 2010, 71 (Suppl. E1): e05-PubMed Higuchi T: Major depressive disorder treatment guidelines in Japan. J Clin Psychiatry. 2010, 71 (Suppl. E1): e05-PubMed
15.
go back to reference Davidson JRT: Major depressive disorder treatment guidelines in America and Europe. J Clin Psychiatry. 2010, 71 (Suppl E1): e04-CrossRefPubMed Davidson JRT: Major depressive disorder treatment guidelines in America and Europe. J Clin Psychiatry. 2010, 71 (Suppl E1): e04-CrossRefPubMed
16.
go back to reference Judd LL, Schettler PJ, Akiskal HS: The prevalence, clinical relevance, and public health significance of subthreshold depressions. Psychiatr Clin North Am. 2002, 25 (4): 685-698. 10.1016/S0193-953X(02)00026-6.CrossRefPubMed Judd LL, Schettler PJ, Akiskal HS: The prevalence, clinical relevance, and public health significance of subthreshold depressions. Psychiatr Clin North Am. 2002, 25 (4): 685-698. 10.1016/S0193-953X(02)00026-6.CrossRefPubMed
17.
go back to reference Targum SD, Pollack MH, Fava M: Redefining affective disorders: relevance for drug development. CNS Neurosci Ther. 2008, 14 (1): 2-9. 10.1111/j.1755-5949.2008.00038.x.CrossRefPubMed Targum SD, Pollack MH, Fava M: Redefining affective disorders: relevance for drug development. CNS Neurosci Ther. 2008, 14 (1): 2-9. 10.1111/j.1755-5949.2008.00038.x.CrossRefPubMed
19.
go back to reference Shorter E: The doctrine of the two depressions in historical perspective. Acta Psychiatr Scand Suppl. 2007, 433: 5-13.CrossRefPubMed Shorter E: The doctrine of the two depressions in historical perspective. Acta Psychiatr Scand Suppl. 2007, 433: 5-13.CrossRefPubMed
20.
go back to reference Imlah NW: An evaluation of alprazolam in the treatment of reactive or neurotic (secondary) depression. Br J Psychiatry. 1985, 146: 515-519. 10.1192/bjp.146.5.515.CrossRefPubMed Imlah NW: An evaluation of alprazolam in the treatment of reactive or neurotic (secondary) depression. Br J Psychiatry. 1985, 146: 515-519. 10.1192/bjp.146.5.515.CrossRefPubMed
21.
go back to reference Monane M, Avorn J: Medication and falls. Causation, correlation, and prevention. Clin Geriatr Med. 1996, 12 (4): 847-858.PubMed Monane M, Avorn J: Medication and falls. Causation, correlation, and prevention. Clin Geriatr Med. 1996, 12 (4): 847-858.PubMed
22.
go back to reference Vermeeren A, Coenen AM: Effects of the use of hypnotics on cognition. Prog Brain Res. 2011, 190: 89-103.CrossRefPubMed Vermeeren A, Coenen AM: Effects of the use of hypnotics on cognition. Prog Brain Res. 2011, 190: 89-103.CrossRefPubMed
23.
go back to reference Gallacher J, Elwood P, Pickering J, Bayer A, Fish M, Ben-Shlomo Y: Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS). J Epidemiol Community Health. 2011, Oct, 66 (10): 869-873.CrossRefPubMed Gallacher J, Elwood P, Pickering J, Bayer A, Fish M, Ben-Shlomo Y: Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS). J Epidemiol Community Health. 2011, Oct, 66 (10): 869-873.CrossRefPubMed
24.
go back to reference Lader MH: Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?. Eu Neuropsychopharmacol. 1999, 9 (Suppl 6): S399-405.CrossRef Lader MH: Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?. Eu Neuropsychopharmacol. 1999, 9 (Suppl 6): S399-405.CrossRef
25.
go back to reference O’brien CP: Benzodiazepine use, abuse, and dependence. J Clin Psychiatry. 2005, 66 (Suppl 2): 28-33.PubMed O’brien CP: Benzodiazepine use, abuse, and dependence. J Clin Psychiatry. 2005, 66 (Suppl 2): 28-33.PubMed
Metadata
Title
Melancholic and reactive depression: a reappraisal of old categories
Authors
Jin Mizushima
Hitoshi Sakurai
Yuya Mizuno
Masaki Shinfuku
Hideaki Tani
Kadunari Yoshida
Chisa Ozawa
Asako Serizawa
Natsuko Kodashiro
Shinya Koide
Atsumi Minamisawa
Eisaku Mutsumoto
Nobuhiro Nagai
Sachiko Noda
Genichiro Tachino
Tatsuichiro Takahashi
Hiroyoshi Takeuchi
Toshiaki Kikuchi
Hiroyuki Uchida
Koichiro Watanabe
Hiroki Kocha
Masaru Mimura
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2013
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/1471-244X-13-311

Other articles of this Issue 1/2013

BMC Psychiatry 1/2013 Go to the issue